These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28210556)

  • 1. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
    Shima H; Yamada A; Ishikawa T; Endo I
    Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
    Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
    Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44
    Chen J; Liu S; Su Y; Zhang X
    Transl Cancer Res; 2020 Mar; 9(3):1652-1659. PubMed ID: 35117513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients.
    Zekri AN; Bahnassy A; Mourad M; Malash I; Ahmed O; Abdellateif MS
    Cancer Cell Int; 2022 Dec; 22(1):423. PubMed ID: 36585652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
    Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells.
    Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
    Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rios-Fuller TJ; Ortiz-Soto G; Lacourt-Ventura M; Maldonado-Martinez G; Cubano LA; Schneider RJ; Martinez-Montemayor MM
    Oncotarget; 2018 Nov; 9(89):35907-35921. PubMed ID: 30542507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer stem cells: clonal origin and therapeutic perspectives.
    Li Y; Lin K; Yang Z; Han N; Quan X; Guo X; Li C
    Oncotarget; 2017 Sep; 8(39):66668-66679. PubMed ID: 29029546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
    Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
    Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.